Press releases | WebDisclosure

Basculer en Français

9560	Companies
188851	Keywords
120589	Articles
100789	Press releases

Home
Press releases

PRESS RELEASE

published on 09/27/2024 at 13:40, 1 year 2 months ago

United Terra Enterprises PLC Announces Results of Extraordinary Shareholders’ Meeting of Eurybia AG
United Terra Enterprises PLC announces successful Eurybia AG shareholders' meeting with approvals for auditors, capital increase, and Articles updates

Capital Increase Shareholders' Meeting United Terra Enterprises PLC Eurybia AG Articles Update
PRESS RELEASE

published on 09/27/2024 at 13:30, 1 year 2 months ago

MIRA Pharmaceuticals Announces New Preclinical Data for Ketamir-2 to Be Presented at the 18th Annual Pain Therapeutics Summit in Boston on October 28-29, 2024
MIRA Pharmaceuticals presents preclinical results at Pain Therapeutics Summit showcasing that Ketamir-2 achieves 100% reversal of neuropathic pain. The innovative therapy targets NMDA receptors for enhanced efficacy

Preclinical Results MIRA Pharmaceuticals Ketamir-2 NMDA Receptor Neuropathic Pain
PRESS RELEASE

published on 09/27/2024 at 13:29, 1 year 2 months ago

Changes in the Executive Board of Schaeffler AG
Schaeffler AG announces changes in the Executive Board, with new appointments and roles effective from October 1, 2024, to align the company for the upcoming merger with Vitesco Technologies AG

Appointments Executive Board Schaeffler AG Financial Officer E-Mobility Division
PRESS RELEASE

published on 09/27/2024 at 13:00, 1 year 2 months ago

Aston Bay and American West Metals Report 22.9m @ 8.5% Cu Intersected at the Storm Project, Nunavut, Canada
Drill results show high-grade copper intersections at Storm Project, suggesting expansion potential. NEAS sealift operation saves $4M on 2025 budget

High-grade Copper Expansion Potential Storm Project NEAS Sealift 2025 Budget
PRESS RELEASE

published on 09/27/2024 at 13:00, 1 year 2 months ago

Press Release: Dupixent approved in China as the first-ever biologic medicine for patients with COPD
Dupixent approved in China as the first-ever biologic medicine for COPD patients, following landmark phase 3 studies. Approval crucial for addressing COPD burden in China

China COPD Dupixent Biologic Medicine Phase 3 Studies
PRESS RELEASE

published on 09/27/2024 at 13:00, 1 year 2 months ago

Communiqué de presse : Dupixent, premier médicament biologique approuvé en Chine pour le traitement de la BPCO
Dupixent, premier médicament biologique approuvé en Chine pour le traitement de la BPCO, réduit les exacerbations et améliore la fonction respiratoire. Approbation suite à études de phase III

Traitement Chine Approbation BPCO Dupixent
PRESS RELEASE

published on 09/27/2024 at 12:50, 1 year 2 months ago

Coinsilium Group Limited: UNAUDITED CONSOLIDATED INTERIM FINANCIAL STATEMENTS FOR THE SIX-MONTH PERIOD ENDED 30 JUNE 2024
Coinsilium Group Limited announces unaudited consolidated interim financial statements for the six-month period ended 30 June 2024. Revenue decreased, profit improved. Corporate agreements and investments made in Web3 projects. Directors' statement provided

Financial Statements Coinsilium Group Limited Web3 Investment Portfolio Directors' Statement
PRESS RELEASE

published on 09/27/2024 at 12:48, 1 year 2 months ago

EQS-Adhoc: BayWa AG: Impairment tests lead to extraordinary depreciation of € 222.2 million (impairment tests in accordance with IAS 36)
BayWa AG reports non-cash impairment losses of €222.2 million in Half-Year Financial Statements 2024 due to impairment tests. BayWa r.e. AG is the most affected subsidiary

BayWa AG Restructuring Dépréciation Impairment Tests Half-year Financial Statements
PRESS RELEASE

published on 09/27/2024 at 12:45, 1 year 2 months ago

Elevating Business Horizons: Hong Kong, London Shape New Collaborative Success
Hong Kong's Financial Secretary Paul Chan leads delegation to London to strengthen ties with European businesses, emphasizes commitment to 'one country, two systems' arrangement

Hong Kong London Coopération Paul Chan European Businesses
PRESS RELEASE

published on 09/27/2024 at 12:42, 1 year 2 months ago

Original-Research: Sernova Corp (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research reaffirms Buy rating for Sernova Corp (ISIN: CA81732W1041) with updated price target of CAD1.90 following positive results in treating type 1 diabetes

First Berlin Equity Research BUY Rating Sernova Corp Type 1 Diabetes CAD1.90

Accesswire

Published on 12/20/2025 at 00:30, 1 day 17 hours ago

Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Published on 12/19/2025 at 22:00, 1 day 20 hours ago

GMV Minerals Inc. Closes Non-Brokered Equity Financing
Published on 12/19/2025 at 18:30, 1 day 23 hours ago

Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 2 days 3 hours ago

Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 2 days 4 hours ago

Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF

View all ACCESSWIRE

EQS Group

Published on 12/21/2025 at 08:55, 9 hours 34 minutes ago

Vantage Markets recognised for real-time threat intelligence collaboration with Trend Micro
Published on 12/20/2025 at 16:45, 1 day 1 hour ago

Shanghai Electric Powers Up Iraq's Energy Future with Major 625MW Efficiency Upgrade
Published on 12/20/2025 at 10:05, 1 day 8 hours ago

FITUR 2026 highlights the strong synergies between Germany and Spain
Published on 12/19/2025 at 22:03, 1 day 20 hours ago

EAMD: Trading resumes on the Düsseldorf Stock Exchange, lawsuit filed by minority shareholders dismissed, capital increase for investments in drone projects in the defense tech sector
Published on 12/19/2025 at 21:40, 1 day 20 hours ago

IMG Saxony-Anhalt: 2026 in Sight - Saxony-Anhalt Sets the Pace for Future Industries

Les Echos

Published on 12/19/2025 at 21:57, 1 day 20 hours ago

Mise à disposition du document d’enregistrement universel
Published on 12/19/2025 at 08:30, 2 days 9 hours ago

Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 2 days 9 hours ago

Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 2 days 11 hours ago

EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 2 days 11 hours ago

EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION

View all LES ECHOS COMFI WIRE